AzTrials
AzTrials

Low Back PainNCT04829448

The Influence of a Protein Nutrition Beverage on Exercise-based Rehabilitation Outcomes in Individuals with Spine Pain.

A study testing Protein supplement in people with Low Back Pain, run by Kamshad Raiszadeh, MD at 1 site in United States.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

SpineZone is an innovative physical therapy program with its focus on treatment of cervical, thoracic, and lumbar conditions through the use of a multi-disciplinary, technology enabled platform. Read more about this study

Who is it for?
Ages 18 to 89 years
Conditions the study is for
Low Back Pain
What is being tested?
Protein supplement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
16 Mar 2022to Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Seeking treatment for spinal conditions, pain or for the prevention of future injury
  • Ability to consume protein shake and follow storage, timing and preparation instructions
  • Indicated by a qualified health care provider to safely participate in an exercise-based rehabilitation program
  • Ability to read and comprehend the English language

Who cannot join

  • Certain medical conditions, diagnosis, physical or psychological or physical exam finding that precludes participation, medications, or contraindications for protein supplement
  • Individuals who are determined by their health care provider to be contraindicated for participation in an exercise-based rehabilitation program
  • Individuals with food allergies to animal based products, nuts, and/or eggs
  • Individuals with consumption preferences omitting non-vegan or vegetarian products
  • Taking protein supplements already
  • History of severe liver disorder
Show all 11Show fewer
  • History of Kidney disorder
  • History of diabetes
  • History of Gastrointestinal malabsorption
  • History of Parathyroid gland disorders
  • Pregnant, postpartum up to six months, lactating, or intention to become pregnant

Trial locations and contacts

1 site in 1 country.

United States1 site
  • SpineZone

    San Diego, California, 92108

Other trials in United States

About this study

SpineZone is an innovative physical therapy program with its focus on treatment of cervical, thoracic, and lumbar conditions through the use of a multi-disciplinary, technology enabled platform. Standard physical therapy modalities including exercise-based rehabilitation as well as patient education on a healthy lifestyle (sleep, nutrition, posture) are employed as part of the standard treatment. As nutrition is a key element in modulating muscle growth and function in response to exercise, providing patients with appropriate access to nutritional supplements that meet the metabolic demands of our exercise program are potentially important to our clinical outcomes.

Read the detailed description

Low back pain manifests itself clinically with pain, loss of strength, difficulty with normal posture, and decreased range of motion. In as many as 60-85% cases, LBP will become a chronic condition, requiring long term care, and even surgery.

Conservative therapy is typically administered until it's no longer a viable option, after which surgical options are considered. Conservative therapy includes physical therapy, medication, steroid injections etc. Physical therapy and exercises are especially central to conservative therapy. Numerous exercise and therapy protocols have been designed with the goal to improve low back muscle strength, thereby alleviating symptoms, and potentially underlying cause of the pathology.

As nutrition is a key element in modulating muscle growth and function in response to exercise, providing patients with appropriate access to nutritional supplements that meet the metabolic demands of our exercise program are potentially important to our clinical outcomes.

The project specifically aims to assess the effect of ensuring adequate nutritional availability of protein, as protein shake, as part of their standard care for treatment of low back pain typically 4-12 weeks duration. In this experiment, we will compare muscle structure and health and correlate improvements with patient-specific characteristics such as demographics, medical history, medication usage, treatment expectations, and symptom severity. Subsequently, this information will enable us to gain valuable insight into physiological response of pathological tissue, and potentially, develop optimal exercise plans to maximally benefit these patients.

AIMS OF THE STUDY

  • To evaluate the adherence and compliance of patients taking a protein nutritional supplement in this patient population.
  • To evaluate the effectiveness of protein nutritional supplementation on improving clinical outcomes.
  • Identify patients (based on patient specific predictors who are most likely to succeed with the addition of nutritional supplementation. The goal of this project is to assess the impact of a nutritional protein supplement on clinical outcomes in individuals with spine pain.

RESEARCH PARTICIPANTS We will recruit up to 100 individuals with LBP of > 3months duration that have been identified by the care providers (ie. Primary care physical, orthopaedic surgeon, or other) to be appropriate and safe for participation in a physical rehabilitation program with nutritional supplementation at SpineZone.

Upon initial evaluation at the SpineZone clinic with a Physical Therapist, participants will be offered the opportunity participate in the study and may receive the protein supplement as part of their standard care. Potentially interested patients will be screened by inclusion and exclusion criteria and as such, written informed consent will be obtained from each patient.

Patients will then be randomly assigned to the treatment (protein supplement) or control group (no protein supplement) and commence their prescribed rehabilitation treatment as per therapist recommendation. Individuals in the randomly assigned supplementation group will be provided the supplement and will be instructed on its use (dosage and frequency).

CONSENT All guidelines for proper consenting will be observed. Consenting will be done in a private room prior to any procedures being performed. Patients will be given ample time to review the document and ask questions. All study procedures will be thoroughly explained and all questions will be answered. Patients will not be placed under any pressure to participate in the study. Consent forms will be obtained by the investigators of the study and/or the study coordinator in the SpineZone clinics.

Withdrawal from the study: If the patient decides at any point to withdraw from the study, they can do so without any of the benefits to which they are entitled changing.

RISK/BENEFITS RATIO The risks to the patients will be minimal. Although there is, future patients may benefit from improvements to surgical procedures and more effective rehabilitation programs which will be derived from patient outcomes.

DATA PRIVACY AND CONFIDENTIALITY A confidentiality breach is a risk associated with data review research; however every measure will be instituted to ensure that patient information is kept confidential. Data analysis worksheets will be kept separate from EMR records. No subject public health information will be collected or shared.

Conditions
Low Back Pain
Being tested
Protein supplement
Keywords
Protein Supplement, Exercise-based Rehabilitation
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Protein supplementDietary supplement

    Protein supplement equivalent to Metagenics Ultrameal

Study groups in NCT04829448
Study groupRoleWhat they receive
Protein Intervention GroupExperimentalPatients who receive the protein nutritional supplement as part of their prescribed exercise-based rehabilitation program.
Receives: Dietary Supplement: Protein supplement
Control GroupNo interventionPatients who receive the prescribed exercise-based rehabilitation program, without protein supplement.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle size

    Change in spine extensor muscle cross sectional area (cm2)

    Measured: 3 months, 6 months, 1 year, 2 years

Secondary outcomes (4)
  1. Symptom inference - change in pain. Visual Analogue Scale (VAS), 0-100mm

    Difference in VAS (in mm) between initial evaluation and endpoint

    Measured: 3 months, 6 months, 1 year, 2 years

  2. Change in disability

    Difference in Oswestry Disability Index (ODI), between evaluation and end point

    Measured: 3 months, 6 months, 1 year, 2 years

  3. Patient Goal Achievement

    Patient Specific Functional Scale (PSFS), 0-10 points

    Measured: 3 months, 6 months

  4. Change in strength (lbs*deg)

    Difference in spine extension torque as measures by isokinetic dynamometer between initial evaluation and endpoint

    Measured: 3 months, 6 months, 1 year, 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2021
  2. Study start16 Mar 2022
  3. Primary completionApr 2026 (estimated)
  4. Study completionApr 2026 (estimated)

Why it stopped: Protein product reconfiguration

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04829448
Sponsor's protocol ID
Protein and Exercise Outcomes
Status last verified
Nov 2024
First submitted
30 Mar 2021
Last updated
29 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Patient data will only be accessible to SpineZone and collaborating research partners (UCSD).

Questions about this trial

What is this clinical trial studying?

A study testing Protein supplement in people with Low Back Pain, run by Kamshad Raiszadeh, MD at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 29 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle size (time frame: 3 months, 6 months, 1 year, 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in